Stock 239 PAK FAH YEOW INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pak Fah Yeow International Limited

Equities

239

BMG6873Y1176

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:00 2024-05-03 am EDT 		5-day change 1st Jan Change
2.12 HKD +1.44% Intraday chart for Pak Fah Yeow International Limited 0.00% +19.77%
Mar. 26 Pak Fah Yeow International Limited Proposes Special Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024 CI
Mar. 26 Pak Fah Yeow International Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 August 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 906.9 841.4 576.5 492.4 386.4 551.6
Enterprise Value (EV) 1 784.2 703.2 459.4 326 207.5 274.3
P/E ratio 24.3 x 23.3 x -15 x 12.9 x 12.9 x 5.25 x
Yield 3.56% 4% 3.46% 4.18% 4.92% 3.84%
Capitalization / Revenue 6.4 x 5.67 x 5.25 x 3.5 x 2.62 x 2.13 x
EV / Revenue 5.54 x 4.74 x 4.19 x 2.32 x 1.4 x 1.06 x
EV / EBITDA 18.2 x 13.2 x 13.1 x 6.16 x 3.82 x 1.82 x
EV / FCF 18 x 18.5 x -35.4 x 5.77 x 7.05 x 2.43 x
FCF Yield 5.55% 5.4% -2.82% 17.3% 14.2% 41.2%
Price to Book 1.2 x 1.11 x 0.86 x 0.7 x 0.55 x 0.72 x
Nbr of stocks (in thousands) 311,640 311,640 311,640 311,640 311,640 311,640
Reference price 2 2.910 2.700 1.850 1.580 1.240 1.770
Announcement Date 4/25/19 4/28/20 4/22/21 4/28/22 4/27/23 4/18/24
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 141.7 148.3 109.8 140.5 147.7 259.6
EBITDA 1 43.16 53.38 35.02 52.94 54.29 150.8
EBIT 1 35.26 45 26.99 45.76 46.8 143.4
Operating Margin 24.89% 30.34% 24.59% 32.56% 31.68% 55.27%
Earnings before Tax (EBT) 1 43.72 44.26 -33.86 46.92 37.77 128.8
Net income 1 37.28 36.05 -38.36 38.19 29.96 105
Net margin 26.32% 24.31% -34.94% 27.17% 20.27% 40.47%
EPS 2 0.1196 0.1157 -0.1231 0.1225 0.0961 0.3371
Free Cash Flow 1 43.53 37.94 -12.98 56.5 29.45 112.9
FCF margin 30.73% 25.58% -11.82% 40.2% 19.93% 43.5%
FCF Conversion (EBITDA) 100.87% 71.07% - 106.73% 54.24% 74.85%
FCF Conversion (Net income) 116.78% 105.25% - 147.95% 98.3% 107.49%
Dividend per Share 2 0.1035 0.1080 0.0640 0.0660 0.0610 0.0680
Announcement Date 4/25/19 4/28/20 4/22/21 4/28/22 4/27/23 4/18/24
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 123 138 117 166 179 277
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 43.5 37.9 -13 56.5 29.4 113
ROE (net income / shareholders' equity) 4.95% 4.75% -5.35% 5.53% 4.23% 14.3%
ROA (Net income/ Total Assets) 2.43% 3.08% 1.98% 3.5% 3.52% 10.4%
Assets 1 1,534 1,171 -1,941 1,090 850.4 1,014
Book Value Per Share 2 2.430 2.440 2.160 2.270 2.270 2.460
Cash Flow per Share 2 0.4000 0.4400 0.3800 0.5300 0.5400 0.8500
Capex 1 1.29 0.44 0.64 0.82 0.16 3.06
Capex / Sales 0.91% 0.3% 0.58% 0.58% 0.11% 1.18%
Announcement Date 4/25/19 4/28/20 4/22/21 4/28/22 4/27/23 4/18/24
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
PAK FAH YEOW INTERNATIONAL LIMITED Stock Pak Fah Yeow International Limited
+19.77% 84.58M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.98% 43.48B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.65B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.56% 14.73B
CIPLA LIMITED Stock Cipla Limited
+14.32% 13.79B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.72% 12.04B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.08B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.90% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 239 Stock
  4. Financials Pak Fah Yeow International Limited